Use of fermented black bean ginger or its extract and composition

By using fermented black bean ginger or its extract, the problem of biotoxicity and slow efficacy of existing drugs in treating liver damage is solved, and the rapid reduction of aminotransferase levels and improvement of liver function is achieved, protecting liver tissues are provided, and a gentle and safe liver is provided. Injury treatment plan.

CN117982557BActive Publication Date: 2024-11-19深圳露泉生命产业有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311847807.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-28
Publication Date
2024-11-19
Estimated Expiration
2043-12-28

AI Technical Summary

Technical Problem

The existing drugs for treating liver injury are biotoxic and have slow efficacy, so they cannot effectively protect the liver tissue structure. There are no reports on the application of fermented black beans or its extracts in liver injury protection.

Method used

By using fermented black bean ginger or its extracts, especially water extracts and alcohol extracts, as drugs to prevent and treat liver damage, it significantly reduces serum ALT and AST levels, improves GSH content in the liver, reduces MDA content, and improves liver tissue as well as improves liver tissue. Learn structure.

Benefits of technology

Fermented black bean ginger or its extract can quickly reduce the level of aminotransferase, improve liver function indicators, have antioxidant stress ability, protect liver tissue, and provide gentle and safe therapeutic effects. It is suitable for the prevention and treatment of liver damage and related diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117982557B_ABST
    Figure CN117982557B_ABST
Patent Text Reader

Abstract

This invention discloses the use of fermented black soybean and ginger, or its extracts, in the preparation of drugs or health products for the prevention and / or treatment of liver injury. Research in this invention shows that fermented black soybean and ginger, or their extracts, can significantly and rapidly reduce transaminase levels, improve liver function indicators, possess antioxidant stress resistance, protect liver histological morphology, and provide comprehensive conditioning. They are mild and safe for the prevention and / or treatment of liver injury, thus offering protection against diseases caused by liver injury and showing promise as a new therapeutic agent for liver injury diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine technology, and more specifically, to use of fermented black bean ginger or an extract thereof, or a composition thereof, in preparing a drug for preventing and / or treating liver damage. Background Art

[0002] The liver is the main organ for absorption, distribution, metabolism and elimination in the human body, and plays a key role in sugar metabolism, protein metabolism, lipid metabolism, etc. Factors such as viral infection, bacterial infection, alcohol, drug-induced liver injury, liver ischemia-reperfusion, and pathogenic liver injury will stimulate the body to produce too many highly reactive oxygen free radicals, induce oxidative stress, and trigger an inflammatory response, which will lead to liver cell apoptosis, hepatitis, liver fibrosis, liver injury and other lesions.

[0003] With the rapid development of medical technology, many studies have been conducted on drugs for the treatment of liver damage, mainly including Chinese herbal medicine, biological drugs, chemical drugs and trace elements. However, some studies have shown that some drugs against liver damage will inevitably produce biological toxicity. It can be seen that the prevention and treatment of liver damage is still a serious issue.

[0004] Traditional Chinese medicine is a treasure of traditional Chinese medicine. Many of them have good therapeutic effects on diseases and do not produce very obvious toxic side effects. Therefore, research and development of traditional Chinese medicine for the treatment of clinical liver injury has important practical significance.

[0005] Douchi ginger, a Chinese medicine name, is also known as the root of Litsea cubeba (Lour.) Pers., a plant of the Lauraceae family. It is distributed in Southwest China, South China, Anhui, Jiangsu, Zhejiang, Jiangxi and other places. Douchi ginger is used as medicine with its root, which is pungent, slightly bitter, warm in nature, and enters the spleen, stomach and liver meridians. It has the effects of dispelling wind, dispersing cold and removing dampness, warming the middle and regulating qi and relieving pain. It is mainly used to treat colds and headaches, cold pain in the heart and stomach, abdominal pain, vomiting and diarrhea, beriberi, edema in pregnant women, rheumatic pain, and traumatic injuries. It is currently reported that it can be used to treat cerebral thrombosis. At present, there are no reports on the protective effect of Douchi ginger or its extracts on liver damage. Summary of the invention

[0006] The purpose of the present invention is to overcome the above-mentioned defects and deficiencies in the prior art and provide the use of fermented black ginger or its extract and its composition in preventing and treating liver damage and the diseases caused by it.

[0007] The above-mentioned object of the present invention is achieved through the following technical solutions:

[0008] Liver damage mainly refers to liver cell damage, liver structure, and abnormal function. Liver damage can stimulate the body to produce too many highly reactive oxygen free radicals, induce oxidative stress, trigger an inflammatory response, lead to liver cell damage and apoptosis, and release too much transaminase into the blood, thereby affecting normal liver function. If not prevented and treated in time, it may induce a series of complications or promote the development of other diseases. The present invention has found through a large number of experiments that fermented black ginger or its extract can be used to prevent and / or treat liver damage, thereby having a preventive and / or therapeutic effect on diseases caused by liver damage.

[0009] In the present invention, the terms "alanine aminotransferase (ALT)" and "aspartate aminotransferase (AST)" are enzymes whose blood levels increase when the liver is damaged, and are enzymes used as liver function indicators using this property.

[0010] In the present invention, the term "reduced glutathione (GSH)" can help maintain normal immune system function and has antioxidant and integrated detoxification effects; the term "malondialdehyde (MDA)" can reflect the degree of lipid peroxidation in the body and indirectly reflect the degree of cell damage.

[0011] Specifically, the present invention verifies the influence of fermented black ginger or its extract on the contents of ALT and AST in serum and GSH and MDA in liver through an acute liver injury model experiment in mice.

[0012] The examination of liver biochemical indicators showed that the serum ALT and AST levels of the model group mice increased significantly 16 hours after subcutaneous injection of CCl4; the two liver function indicators of the model group were significantly different from those of the control group ( P <0.01, the high, medium and low dose groups of Douchi ginger water extract and alcohol extract all showed improvement compared with the model group, and the improvement effect of Douchi ginger alcohol extract high, medium and low dose groups was more obvious ( P <0.01).

[0013] The oxidative stress level showed that the GSH and MDA contents in the liver of mice in the model group were significantly different from those in the blank group ( P <0.05), indicating that the model was successfully established. Compared with the model group, the GSH content in the liver of the silibinin group showed an upward trend, and the MDA content was significantly increased ( P <0.01); compared with the model group, the GSH in the liver of the high, medium and low doses of Douchi ginger water extract groups showed an upward trend, and the GSH in the liver of the low dose Douchi ginger alcohol extract group increased significantly ( P<0.05), the GSH content in the liver of the high and medium dose groups of Douchi ginger alcohol extract increased significantly ( P <0.01); compared with the model group, the MDA content in the liver of the fermented black bean ginger water / alcohol extract group was significantly different ( P <0.01).

[0014] The present invention further found through liver pathology and histological examination that the normal tissue structure of the liver in the model group disappeared, the hepatic sinusoids disappeared, and balloon-like degeneration was visible; the hepatocytes were generally degenerated, necrotic or the nuclei were condensed and dissolved, and a large number of inflammatory cells infiltrated; compared with the model group, the serum biochemical level of the fermented black bean ginger administration group was significantly reduced, the degree of liver cell damage and inflammatory infiltration in mice was significantly reduced, the lobule structure was clear, the hepatic cords and hepatic sinusoids had no obvious lesions, and the cytoplasm was evenly colored.

[0015] The drugs commonly used in the prior art for treatment or prevention, such as the positive drug silymarin used in the present invention, have low bioavailability, poor absorption and utilization in the intestine after administration, slow efficacy, and relatively long course of treatment. Other drugs, such as bifendate, can significantly and rapidly reduce transaminase, but do not significantly change the histology of the liver, and actually have poor anti-inflammatory and hepatocyte protection effects. The fermented black ginger or its extract of the present invention can significantly and rapidly reduce transaminase, protect the histological morphology of the liver, can be used for comprehensive conditioning, and is gentle and safe.

[0016] Therefore, the present invention provides the following uses of fermented black ginger or its extract:

[0017] Use of fermented black ginger or its extract in preparing a medicine for preventing and / or treating liver damage.

[0018] Furthermore, the liver injury is acute liver injury.

[0019] As mentioned above, if liver damage is not prevented and treated in time, it may induce a series of complications or promote the development of other diseases. Douchi ginger or its extracts can be used to prevent and / or treat liver damage, thereby preventing and treating diseases caused by liver damage.

[0020] Therefore, the present invention also provides the use of fermented black ginger or its extract in the preparation of a medicament for preventing and / or treating diseases caused by liver damage or diseases and / or conditions related to diseases caused by liver damage. The diseases and / or conditions related to diseases caused by liver damage refer to other diseases or conditions caused by liver damage, which may occur due to liver damage, or be alleviated or disappear after liver damage is treated.

[0021] The specific types of diseases caused by liver damage are not limited in the present invention. As long as the diseases are caused by liver damage, they are within the protection scope of the present invention, including but not limited to acute liver damage, chronic liver damage, liver fibrosis, cirrhosis, hepatitis, liver cancer, fatty liver, liver failure, etc., for example, liver damage, fatty liver, hepatitis, cirrhosis, liver failure, etc. caused by factors such as alcohol.

[0022] In a preferred embodiment, the disease is acute liver injury or chronic liver injury.

[0023] There are many causes of liver damage, mainly drug poisoning, viral infection, excessive alcohol intake, immune response, contact with chemical toxic substances in the environment, radiation damage, etc. The fermented black ginger or its extract of the present invention has a therapeutic or preventive effect on diseases caused by liver damage. The cause of liver damage is not limited. As long as the liver cells are damaged, the liver structure and function are abnormal, the liver damage is within the scope of the present invention.

[0024] In a preferred embodiment, the liver damage is liver damage caused by alcohol, virus, drug and chemical toxic substances.

[0025] The term "prevention and / or treatment" means that the disease or disorder described in the present invention can be treated, prevented, alleviated and / or alleviated in a subject.

[0026] The term "disease and / or condition" refers to a physical condition of the subject, which physical condition is associated with the diseases and / or conditions described in the present invention.

[0027] The drug can be used for patients or other animals that receive the drug of the present invention to treat, prevent, alleviate and / or relieve the diseases or symptoms of the present invention. In a preferred embodiment, the drug is used for mammals, including but not limited to humans, cattle, horses, sheep, pigs, goats, rabbits, cats, dogs, mice and any other mammals that have livers and can cause damage.

[0028] In a preferred embodiment, the medicament is for use in humans.

[0029] The dosage of the drug of the present invention depends on many factors, such as the nature and severity of the disease to be prevented or treated, the sex, age, weight and individual response of the patient or animal, the route of administration and the number of administrations, etc. The above dosage can be administered in a single dosage form or divided into several, such as two, three or four dosage forms. The dosage level must be selected based on the specific route of administration, the severity of the condition to be treated, and the condition and previous medical history of the patient to be treated.

[0030] However, it should be recognized that the total daily dosage of the drug of the present invention must be determined by the attending physician within the scope of sound medical judgment. For any particular patient, the specific therapeutically effective dosage level must be determined based on a variety of factors, including the disorder being treated and the severity of the disorder; the specific composition used; the patient's age, weight, general health, sex and diet; administration time, route of administration and excretion rate; duration of treatment; drugs used in combination or concurrently; and similar factors known in the medical field. For example, it is practiced in the art to start the administration of a dose lower than the level required to obtain the desired therapeutic effect and gradually increase the dose until the desired effect is obtained.

[0031] In a further preferred embodiment, the drug is administered in a single dose form, i.e., a single dose form. In a further preferred embodiment, the single dose administered is equivalent to 5g to 200g of Douchi ginger raw medicine, for example, it can be 5g, 8g, 10g, 15g, 20g, 30g, 40g, 50g, 60g, 70g, 80g, 90g, 100g, 110g, 120g, 130g, 140g, 150g, 160g, 170g, 180g, 190g, and more preferably 15g to 100g of Douchi ginger raw medicine. It should be understood by those skilled in the art that, under normal circumstances, the weight of a person is calculated as 60kg. If the weight of the person is not 60kg, it can be converted according to this standard.

[0032] The drug of the present invention can be administered in a unit dosage form, and the administration route can be enteral or parenteral, such as oral, intramuscular, subcutaneous, nasal, oral mucosa, skin, peritoneum or rectum, etc. The dosage form is, for example, tablets, capsules, dripping pills, aerosols, pills, powders, solutions, suspensions, emulsions, granules, liposomes, transdermal agents, buccal tablets, suppositories, freeze-dried powder injections, etc. It can be a common preparation, a sustained-release preparation, a controlled-release preparation and various microparticle delivery systems.

[0033] The Douchi ginger extract of the present invention can be a Douchi ginger water extract or a Douchi ginger alcohol extract, or a mixture of water-alcohol extracts.

[0034] As a preferred embodiment, dried fermented black ginger is used to prepare the fermented black ginger extract.

[0035] The method for extracting the fermented black ginger water extract can use any water extraction method in the art. In a preferred embodiment, the present invention uses the following method to prepare the fermented black ginger water extract:

[0036] Crush: Take the fermented black bean ginger and crush it into coarse powder;

[0037] Water heating reflux extraction: Take the coarse powder and add water, reflux extraction, filter and add water again, repeat the above reflux extraction steps, and then combine the filtrate;

[0038] Concentrating the filtrate: concentrating the filtrate to obtain the fermented black ginger water extract.

[0039] The water can be any form of water in this field, such as purified water, deionized water, secondary water, etc.

[0040] The number of times of the reflux extraction is not limited in the present invention, and can be one, two, three, four or more times.

[0041] The concentration method may be any method known in the art, such as reduced pressure concentration.

[0042] The extraction method of the fermented black bean curd ginger alcohol extract can use any alcohol extraction method in the art. In a preferred embodiment, the present invention uses the following method to prepare the fermented black bean curd ginger alcohol extract:

[0043] Crush: Take the fermented black bean ginger and crush it into coarse powder;

[0044] Alcohol heating reflux extraction: Take the crude powder and add alcohol, reflux extraction, filter and add alcohol again, repeat the above reflux extraction steps, and then filter the solution;

[0045] Concentrating the filtrate: concentrating the filtrate to obtain the fermented black bean curd ginger alcohol extract.

[0046] The alcohol may be any common alcohol in the art, such as methanol, propanol, butanol, etc.

[0047] The number of times of the reflux extraction is not limited in the present invention, and can be one, two, three, four or more times.

[0048] The concentration method may be any method known in the art, such as reduced pressure concentration.

[0049] In a preferred embodiment, the medicine optionally contains a pharmaceutically acceptable carrier or excipient. Including but not limited to lactose, glucose, sucrose, sorbitol, mannitol, starch, gum arabic, calcium phosphate, alginate, gel, calcium silicate, microcrystalline cellulose, polyvinyl pyrrolidone, cellulose, water, syrup, methylcellulose, methyl hydroxybenzoate, propyl hydroxybenzoate, talc, magnesium stearate and mineral oil, but are not limited thereto. In addition to the above-mentioned ingredients, the medicine of the present invention may also contain lubricants, wetting agents, sweeteners, flavoring agents, emulsifiers, suspending agents and preservatives, etc.

[0050] In a preferred embodiment, the drug for preventing and / or treating diseases caused by liver damage in the present invention may further contain one or more other active substances. The other active substances refer to other substances that have activity and produce certain functions other than Douchi ginger or its extracts. The active substances may be active substances for treating or preventing diseases caused by liver damage, or they may be active substances for assisting in treating or preventing diseases caused by liver damage, or they may not treat diseases caused by liver damage, but they may play a positive effect or function in other convenient ways. The active substances may be, for example, Artemisia capillaris, Radix rehmanniae, Cortex moutan, Rhizoma coptidis, Radix rehmanniae, Radix bupleuri, Herba prunellae, Achyranthis bidentatae, Radix scutellariae, etc. or one or more of their extracts. The other active substances may be original medicinal materials or extracts thereof (e.g., water extracts, alcohol extracts, or extracts of alcohol-water mixtures).

[0051] The present invention further provides a composition for preventing and / or treating diseases caused by liver damage, wherein the composition comprises fermented black ginger or an extract thereof as the only effective ingredient.

[0052] The term "composition" is intended to encompass a product comprising the specified ingredients in the specified amounts, as well as any product which results, directly or indirectly, from combination of the specified ingredients in the specified amounts.

[0053] In a preferred embodiment, the composition further comprises one or more pharmaceutically acceptable carriers or excipients. The one or more pharmaceutically acceptable carriers or excipients are any of the carriers or excipients described above.

[0054] In a preferred embodiment, the composition further comprises one or more other active substances. The one or more other active substances are any of the other active substances described above.

[0055] The disease caused by liver damage is any of the diseases caused by liver damage described above.

[0056] The fermented black ginger extract is any of the fermented black ginger extracts described above.

[0057] The composition according to any one of the present invention may be in the form of an injection, oral solution, capsule, tablet, granule, or extract remix.

[0058] The composition according to any one of the present invention can be administered in a single dose form, and the administration route can be enteral or parenteral, such as oral, intramuscular, subcutaneous, nasal, oral mucosa, skin, peritoneum or rectum, etc. The dosage form is, for example, tablets, capsules, dripping pills, aerosols, pills, powders, solutions, suspensions, emulsions, granules, liposomes, transdermal agents, buccal tablets, suppositories, freeze-dried powder injections, etc. It can be a common preparation, a sustained-release preparation, a controlled-release preparation and various microparticle delivery systems.

[0059] The dosage of the composition according to any one of the present invention can be converted with reference to the dosage of Alpinia galanga or its extract as described above.

[0060] Compared with the prior art, the present invention has the following beneficial effects:

[0061] The present invention provides the use of Alpinia galanga or its extract in the prevention and / or treatment of liver injury. The research of the present invention shows that Alpinia galanga or its extract can significantly and rapidly decrease transaminase, improve liver function indexes, has the ability to antioxidize stress level, protect the histological morphology of the liver, can comprehensively condition, is mild and safe, can prevent and / or treat liver injury, thus has a protective effect on diseases caused by liver injury, and is expected to become a new therapeutic drug for liver injury diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] Figure 1 Changes in serum alanine aminotransferase (ALT) of mice in different groups;

[0063] Figure 2 Changes in serum aspartate aminotransferase (AST) of mice in different groups;

[0064] Figure 3 Changes in reduced glutathione (GSH) in liver tissues of mice in different groups;

[0065] Figure 4 Changes in malondialdehyde (MDA) in liver tissues of mice in different groups;

[0066] Figure 5 H&E sections of livers of mice in different groups. DETAILED DESCRIPTION OF THE INVENTION

[0067] The present invention will be further described below in conjunction with the accompanying drawings of the specification and specific embodiments, but the embodiments do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.

[0068] Unless otherwise specified, the reagents and materials used in the following examples are all commercially available.

[0069] Experimental materials:

[0070] Animals: SPF-grade male C57BL / 6 mice, weighing 22 (±2) g, 7 weeks old. Purchased from Zhuhai Besttone Biotechnology Co., Ltd., animal license number: [SCXK (Guangdong) 2022-0051].

[0071] Test samples: Alpinia galanga, purchased from Guangxi Yulin Traditional Chinese Medicine Market.

[0072] Reagents: 95% ethanol (AR), Shanghai MacLean Biochemical Technology Co., Ltd.;

[0073] Carbon tetrachloride (HPLC), Shanghai MacLean Biochemical Technology Co., Ltd.;

[0074] Olive oil (pharmaceutical grade), Shanghai MacLean Biochemical Technology Co., Ltd.;

[0075] Liver function and oxidative stress detection kits, Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.;

[0076] Silybin (SY), Shanghai Aladdin Biochemical Technology Co., Ltd.

[0077] Example 1 Preparation of Douchi ginger extract

[0078] In this embodiment, alcohol extraction and water extraction are performed on fermented black bean ginger respectively, and the specific methods are as follows:

[0079] 1. Alcohol extraction

[0080] (1) Preliminary crushing: Take the fermented black beans and ginger root and crush it into coarse medicinal powder.

[0081] (2) Ethanol heating reflux extraction: Take the dried crude powder of the Chinese herbal medicine, add 8 times the mass of 95% ethanol, reflux extract at 80°C for 1 hour, filter, add 8 times the mass of 95% ethanol again, reflux extract at 80°C for 1 hour, filter, and combine the two filtrates.

[0082] (3) Filtrate concentration: The filtrate is concentrated under reduced pressure at 40°C until the relative content of the original medicinal material is 1 g / mL.

[0083] 2. Water extraction

[0084] (1) Preliminary crushing: Take the fermented black beans and ginger root and crush it into coarse medicinal powder.

[0085] (2) Pure water heating reflux extraction: Take the dried crude powder of Chinese herbal medicine, add 8 times the weight of pure water, reflux extract at 120℃ for 1 hour, filter, add 8 times the weight of pure water again, reflux extract at 120℃ for 1 hour, filter, and combine the two filtrates.

[0086] (3) Filtrate concentration: The filtrate is concentrated under reduced pressure at 60°C until the relative content of the original medicinal material is 1 g / mL.

[0087] Example 2 Study on the effect of Douchi ginger extract on carbon tetrachloride-induced acute liver injury in mice

[0088] 1. Experimental methods

[0089] (1) Animal grouping and drug administration

[0090] 70 mice were randomly divided into blank control group, model group, low-dose dosing group, medium-dose dosing group, high-dose dosing group, low-dose dosing group, medium-dose dosing group, high-dose dosing group and positive control group according to body weight. Among them, the positive control group was given silybin (SY) 150mg / kg body weight / day, the low-dose dosing group was given 2.5g / kg body weight per day, the medium-dose group was given 5g / kg body weight per day, and the high-dose group was given 7.5g / kg body weight per day by intragastric administration once a day for 7 days.

[0091] (2) Establishment of CCl4 acute liver injury model

[0092] Two hours after the last administration, all groups except the blank group were subcutaneously injected with 10% (v:v) CCl4 dissolved in olive oil (10 ml / kg) to induce an acute liver injury model; the blank group was subcutaneously injected with an equal volume of olive oil.

[0093] (3) Sample collection and processing

[0094] After the mice were anesthetized with sodium pentobarbital 16 hours after the injection of CCl4, the mice were killed by orbital blood sampling and the liver was separated for subsequent testing. The whole blood of the mice was left at room temperature for 30 minutes, centrifuged at 4°C, 3000rpm for 15 minutes, and the supernatant was taken to measure liver function indicators (ALT, AST). The liver tissue oxidative stress indicators (GSH, MDA) of the mice were taken, and the same part of the liver was taken for histopathological examination.

[0095] (4) Determination of biochemical indicators

[0096] Alanine aminotransferase (ALT) was detected using a kit method, purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd., batch number 20230426;

[0097] Aspartate aminotransferase (AST) was purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd., batch number 20230427.

[0098] (5) Determination of oxidative stress indicators

[0099] Reduced glutathione (GSH) was detected using a kit method, purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd., batch number 20230926;

[0100] Malondialdehyde (MDA) was purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd., batch number 20230922.

[0101] (6) Pathological section processing

[0102] Liver tissues from the right lobe of the liver (with the largest cross-section, portal vein area and central vein area) of different mice were fixed in 4% paraformaldehyde; paraffin sections were made through the steps of washing, dehydration, transparency, wax immersion, embedding, slicing and sticking, dewaxing, H&E staining, dehydration, transparency, and sealing, and histological lesions were observed under an optical microscope.

[0103] (7) Statistical data processing

[0104] All experimental data were statistically analyzed using GraPhPad Prism6.0 software. When the measurement data met the normal distribution, one-way ANOVA was used. If not, Tamhanes T2 (M) test was used. The number of each group in data analysis was n=5, #, P <0.05;##, P <0.01; compared with model control, *, P <0.05; ** , P <0.01.

[0105] 2. Results

[0106] (1) Serum ALT and AST levels of mice in each group

[0107] exist Figure 1 In the figure, the ALT activity of the model group (CCl4) was significantly higher than that of the control group (NC), indicating that the model was successfully established. The Douchi ginger extract prepared in Example 1 can significantly reduce the ALT activity. As can be seen from the figure, the silybin group (SY), Douchi ginger water extract low-dose group (DCJ-SL), medium-dose group (DCJ-SM), high-dose group (DCJ-SH) and Douchi ginger alcohol extract low-dose group (DCJ-CL) have a trend of reducing ALT activity, but there is no significant difference compared with the model group; while the Douchi ginger alcohol extract medium-dose group (DCJ-CM) and high-dose group (DCJ-CH) can significantly reduce ALT activity ( P <0.05), indicating that the active ingredients of fermented black ginger can be easily extracted by ethanol.

[0108] exist Figure 2 The AST activity of the model group (CCl4) was significantly higher than that of the control group (NC), indicating that the model was successfully established. The fermented black ginger extract prepared in Example 1 can significantly reduce the AST activity. As can be seen from the figure, the fermented black ginger water extract low-dose group (DCJ-SL), medium-dose group (DCJ-SM), high-dose group (DCJ-SH) and fermented black ginger alcohol extract high-dose group (DCJ-CH), medium-dose group (DCJ-CM) all have very good effects, and the AST values ​​are significantly different from those of the model group ( P<0.05), especially the AST activity of the high-dose group of Douchi ginger alcohol extract (DCJ-CH) and the medium-dose group of Douchi ginger alcohol extract (DCJ-CM) showed a very significant difference ( P <0.01).

[0109] (2) GSH and MDA levels in the liver of mice in each group

[0110] exist Figure 3 The GSH content in liver tissue of the model group (CCl4) was significantly lower than that of the control group (NC). P <0.05), indicating that the model was successfully established. The fermented ginger extract prepared in Example 1 can significantly increase the content of GSH in liver tissue. It can be seen from the figure that the silybin group (SY), the fermented ginger water extract low-dose group (DCJ-SL), the medium-dose group (DCJ-SM), and the high-dose group (DCJ-SH) have a trend of increasing the GSH content, but there is no significant difference compared with the model group; while the fermented ginger alcohol extract low-dose group (DCJ-CL), the medium-dose group (DCJ-CM), and the high-dose group (DCJ-CH) can significantly increase the GSH content ( P <0.05).

[0111] exist Figure 4 The MDA content in liver tissue of the model group (CCl4) was significantly higher than that of the control group (NC). P <0.05), indicating that the model was successfully established. The fermented ginger extract prepared in Example 1 can increase the content of MDA in liver tissue. It can be seen from the figure that both the high-dose group (DCJ-SH) and low-dose group (DCJ-SL) of fermented ginger water extract and the high-dose group (DCJ-CH) and medium-dose group (DCJ-CM) and low-dose group (DCJ-CL) of fermented ginger alcohol extract can reduce the content of MDA in liver tissue, especially the high-dose group (DCJ-CH) of fermented ginger water extract can significantly reduce the content of MDA in liver tissue in mice.

[0112] (3) Pathological sections of liver of mice in each group

[0113] Pathological sections of the liver tissues of mice in the normal group, model group, silybin group, and high-, medium-, and low-dose groups of fermented black bean ginger water / alcohol extract were performed. Figure 5 As shown in the figure, the normal liver control group (NC) had clear lobule structure, no obvious lesions in liver cells, abundant cytoplasm, and clear nuclear structure. In the model group (CCl4) liver, liver cells were generally degenerated, necrotic or nuclear condensation and dissolution, and a large number of inflammatory cells infiltrated.

[0114] As can be seen from the figure, whether it is the high-dose group (DCJ-SH), medium-dose group (DCJ-SM) and low-dose group (DCJ-SL) of fermented black ginger water extract and the high-dose group (DCJ-CH), medium-dose group (DCJ-CM) and low-dose group (DCJ-CL) of fermented black ginger alcohol extract, the liver lobule structure of the mice after administration is clear, the hepatic cords and sinusoids have no obvious lesions, and the cytoplasm is evenly colored, especially the high-dose group (DCJ-CH) of fermented black ginger alcohol extract. After administration, the liver lobule structure of the mice is clear, the hepatocytes have no obvious abnormalities, the cytoplasm is abundant, the nuclear structure is clear, and it is much better than the positive control group administered with silybin (SY).

[0115] From the above results, it can be seen that fermented black ginger or its extract can significantly and rapidly reduce transaminase, improve liver function indicators, have the ability to resist oxidative stress levels, protect the histological morphology of the liver, can be comprehensively conditioned, gentle and safe, and can be used to prevent and / or treat liver damage, thereby having a protective effect on diseases caused by liver damage, and is expected to become a new therapeutic drug for liver damage diseases.

[0116] Although the embodiments of the present invention are described above, the present invention is not limited to the above specific embodiments and application fields, and the above specific embodiments are only illustrative and instructive, but not restrictive. A person skilled in the art can make many forms under the guidance of this specification and without departing from the scope of protection of the claims of the present invention, all of which belong to the protection of the present invention.

Claims

1. Use of fermented black ginger or its extract as the sole active ingredient in the preparation of a medicament for preventing and / or treating acute liver injury.

2. The use according to claim 1, characterized in that: The cause of the acute liver injury is selected from any one or more of trauma, drugs, alcohol, chemical toxic substances, viruses or autoimmunity.

3. The use according to claim 1 or 2, characterized in that: A single dose of the medicine is equivalent to 5g to 200g of the raw drug of fermented black beans and ginger.

4. The use according to claim 3, characterized in that: A single dose of the medicine is equivalent to 15g to 100g of the raw drug of fermented black beans and ginger.

5. The use according to claim 1 or 2, characterized in that: The fermented black ginger extract is a fermented black ginger water extract, a fermented black ginger alcohol extract or a mixture of water-alcohol extracts.

6. The use according to claim 5, characterized in that: The preparation method of the fermented black bean curd ginger water extract is as follows: Crush: Take the fermented black bean ginger and crush it into coarse powder; Water heating reflux extraction: Take the coarse powder and add water, reflux extraction, filter and add water again, repeat the above reflux extraction steps, and then combine the filtrate; Concentrating the filtrate: concentrating the filtrate to obtain the fermented black ginger water extract.

7. The use according to claim 5, characterized in that: The preparation method of the fermented black beans and ginger alcohol extract is as follows: Crush: Take the fermented black bean ginger and crush it into coarse powder; Alcohol heating reflux extraction: Take the crude powder and add alcohol, reflux extraction, filter and add alcohol again, repeat the above reflux extraction steps, and then filter the solution; Concentrating the filtrate: concentrating the filtrate to obtain the fermented black bean curd ginger alcohol extract.